Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
Conditions
Drug Monitoring · Carcinoma, Non-Small-Cell Lung · Lung Cancer · Anaplastic Lymphoma Kinase Gene Mutation · Anaplastic Lymphoma Kinase Gene Translocation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Gustave Roussy, Villejuif, Val-de-Marne, France
Contact: Study coordinator (B. Besse, PhD)Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Contact: Study coordinator (M.M. van den Heuvel, PhD)Maastricht University Medical Center +, Maastricht, Limburg, Netherlands
Contact: Study coordinator (L.E.L. Hendriks, PhD)The Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (A.J. de Langen, PhD)Amsterdam University Medical Center, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (S.M.S. Hashemi, Msc)Leiden University Medical Center, Leiden, South Holland, Netherlands
Contact: Study coordinator (E.F. Smit, PhD)Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (A.C. Dingemans, PhD)University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (A.J. van der Wekken, PhD)
Study leads
A.J. van der Wekken, PhD
Principal Investigator
University Medical Center Groningen